Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Betaxon (levobetaxolol Hydrochloride) Ophthalmic Suspension
Company:  Alcon Research, Ltd.
Application No.:  021114
Approval Date: 2/23/2000


Date created: July 112005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.